OBJECTIVE: To elucidate the influence of drug-eluting stents (DESs) on interventional therapy of de novo unprotected left main stem (LMS) lesions in a hospital with on-site cardiac surgery. METHODS AND RESULTS: A retrospective study of all patients with unprotected LMS angioplasty from 1999 to 2005 was conducted with regard to clinical and procedural data, and follow-up data. Fifty-four patients with unprotected LMS stenosis were treated inter-ventionally. Of these patients, 16 were treated with DESs. Seven patients presented with cardiogenic shock. During their hospital stay, four patients died (all treated with bare metal stents [BMSs], three initially presenting with cardiogenic shock). Follow-up data for 53 patients (98%) were obtained. Median follow-up time was 24 months (25th percentile, 12 months; 75th percentile, 35 months). Survival after nine months was 87% (81% from the BMS-treated group, and 100% from the DES-treated group). Control angiography had been performed in 36 patients (67%). Patients with unprotected LMS with an angiographic follow-up had a higher nine-month survival rate than patients without (36 of 36 patients [100%] versus 10 of 17 patients [59%], respectively; P<0.0001). Target lesion revascularization rate was 19% in both the BMS and the DES groups. Methods of revascularization did not vary significantly between the groups. CONCLUSIONS: In the present study of selected patients with LMS stenosis, the use of DESs showed a low mortality rate but did not have a clear effect on target lesion revascularization rate compared with BMSs. A close follow-up appears to be mandatory to achieve acceptable results.
OBJECTIVE: To elucidate the influence of drug-eluting stents (DESs) on interventional therapy of de novo unprotected left main stem (LMS) lesions in a hospital with on-site cardiac surgery. METHODS AND RESULTS: A retrospective study of all patients with unprotected LMS angioplasty from 1999 to 2005 was conducted with regard to clinical and procedural data, and follow-up data. Fifty-four patients with unprotected LMS stenosis were treated inter-ventionally. Of these patients, 16 were treated with DESs. Seven patients presented with cardiogenic shock. During their hospital stay, four patients died (all treated with bare metal stents [BMSs], three initially presenting with cardiogenic shock). Follow-up data for 53 patients (98%) were obtained. Median follow-up time was 24 months (25th percentile, 12 months; 75th percentile, 35 months). Survival after nine months was 87% (81% from the BMS-treated group, and 100% from the DES-treated group). Control angiography had been performed in 36 patients (67%). Patients with unprotected LMS with an angiographic follow-up had a higher nine-month survival rate than patients without (36 of 36 patients [100%] versus 10 of 17 patients [59%], respectively; P<0.0001). Target lesion revascularization rate was 19% in both the BMS and the DES groups. Methods of revascularization did not vary significantly between the groups. CONCLUSIONS: In the present study of selected patients with LMS stenosis, the use of DESs showed a low mortality rate but did not have a clear effect on target lesion revascularization rate compared with BMSs. A close follow-up appears to be mandatory to achieve acceptable results.
Entities:
Keywords:
Angioplasty; Drug-eluting stents; Left main stem
Authors: Michael S Lee; Nikhil Kapoor; Faizi Jamal; Lawrence Czer; Joseph Aragon; James Forrester; Saibal Kar; Suhail Dohad; Robert Kass; Neal Eigler; Alfredo Trento; Prediman K Shah; Raj R Makkar Journal: J Am Coll Cardiol Date: 2006-01-06 Impact factor: 24.094
Authors: Marjo Hordijk-Trion; Mattie Lenzen; William Wijns; Peter de Jaegere; Maarten L Simoons; Wilma J M Scholte op Reimer; Michel E Bertrand; Nestor Mercado; Eric Boersma Journal: Eur Heart J Date: 2006-01-19 Impact factor: 29.983
Authors: Marco Valgimigli; Patrizia Malagutti; Jiro Aoki; Héctor M Garcia-Garcia; Gaston A Rodriguez Granillo; Carlos A G van Mieghem; Jurgen M Ligthart; Andrew T L Ong; George Sianos; Evelyn Regar; Ron T Van Domburg; Pim De Feyter; Peter de Jaegere; Patrick W Serruys Journal: J Am Coll Cardiol Date: 2006-01-18 Impact factor: 24.094
Authors: Matthew J Price; Ecaterina Cristea; Neil Sawhney; John A Kao; Jeffrey W Moses; Martin B Leon; Ricardo A Costa; Alexandra J Lansky; Paul S Teirstein Journal: J Am Coll Cardiol Date: 2006-01-06 Impact factor: 24.094
Authors: Arie Pieter Kappetein; Keith D Dawkins; Friedrich W Mohr; Marie Claude Morice; Michael J Mack; Mary E Russell; Jose Pomar; Patrick W J C Serruys Journal: Eur J Cardiothorac Surg Date: 2006-02-23 Impact factor: 4.191
Authors: Sanjay B Pandya; Young-Hak Kim; Sheridan N Meyers; Charles J Davidson; James D Flaherty; Duk-Woo Park; Anuj Mediratta; Karen Pieper; Eric Reyes; Robert O Bonow; Seung-Jung Park; Nirat Beohar Journal: JACC Cardiovasc Interv Date: 2010-06 Impact factor: 11.195